Paula and Bobby
Parents of Lillie
Microphthalmia, Syndromic 2
What is Microphthalmia, Syndromic 2?
It is a rare genetic syndrome also known as Marashi-Gorlin or OFCD syndrome. The syndrome presents with multiple congenital abnormalities that affect the face, dental and heart. It also includes eye abnormalities.
What gene changes cause Microphthalmia, Syndromic 2?
Mutations to the BCOR gene are responsible for the syndrome. The syndrome is inherited in an X-linked dominant pattern.
In the case of autosomal dominant inheritance just one parent is the carrier of the gene mutation, and they have a 50% chance of passing it onto each of their children. Syndromes inherited in an autosomal dominant inheritance are caused by just one copy of the gene mutation.
What are the main symptoms of Microphthalmia, Syndromic 2?
The main symptoms of the syndrome include the following:
Eye anomalies: cataracts present at birth, secondary glaucoma and very small eyes, in some cases the ocular tissue is missing completely and in some cases these anomalies can contribute to vision loss
Facial features and abnormalities: a long and narrow face, high nasal bridge, pointed nose with a cleft or divide at the end of it and a cleft palate
Heart and cardiac defects: atrial septal defect, ventricular septal defect, floppy mitral valve
Dental issues: delayed eruption of secondary teeth, primary teeth that are delayed in falling out, teeth with enlarged roots
How does someone get tested for Microphthalmia, Syndromic 2?
The initial testing for Microphthalmia, Syndromic 2 can begin with facial analysis screening, through the FDNA Telehealth telegenetics platform, which can identify the key markers of the syndrome and outline the need for further testing. A consultation with a genetic counselor and then a geneticist will follow.
Based on this clinical consultation with a geneticist, the different options for genetic testing will be shared and consent will be sought for further testing.
What is FDNA Telehealth?
FDNA Telehealth is a leading digital health company that provides faster access to accurate genetic analysis.
With a hospital technology recommended by leading geneticists, our unique platform connects patients with genetic experts to answer their most pressing questions and clarify any concerns they may have about their symptoms.
Benefits of FDNA Telehealth
Our platform is currently used by over 70% of geneticists and has been used to diagnose over 250,000 patients worldwide.
FDNA Telehealth provides facial analysis and screening in minutes, followed by fast access to genetic counselors and geneticists.
Ease of Use
Our seamless process begins with an initial online diagnosis by a genetic counselor and follows by consultations with geneticists and genetic testing.
Accuracy & Precision
Advanced artificial intelligence (AI) capabilities and technology with a 90% accuracy rate for a more accurate genetic analysis.
Faster access to genetic counselors, geneticists, genetic testing, and a diagnosis. As fast as within 24 hours if required. Save time and money.
Privacy & Security
We guarantee the utmost protection of all images and patient information. Your data is always safe, secure, and encrypted.